EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment and prevention of disorders mediated by LA-paf or endothelial cells



Treatment and prevention of disorders mediated by LA-paf or endothelial cells



Official Gazette of the United States Patent & Trademark Office Patents 1221(3), 19-JUL-99



The invention refers to the composition of substances to prevent and treat endothelial cell-mediated disorders with pathological differentiation of endothelial cells, for example, in response to insulin, lipids, lipoproteins or LA-paf. The invention refers to simple methods to test and use antagonists against LA-paf, paf and very high affinity receptors on endothelial cells which can also be cultured on soluble particles for screening procedures. According to the invention genes producing very high affinity receptors, for example, in response to growth factors such as insulin. These genes can be transferred from adherent endothelial cell lines to soluble cells using standard procedures. Antagonists against LA-paf, paf and very high affinity receptors are administered by preference to healthy persons having risk factors to protect against aging and metabolic, genetic, chronicle, idiopathic, inflammatory or degenerative disorders. The antagonists can be administered by preference with food or topically, for example, with beauty products.

(PDF 0-2 workdays service: $29.90)

Accession: 035980017

Download citation: RISBibTeXText



Related references

Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders. Japanese Heart Journal 16(1): 76-97, 1975

Hyper reactive arterial endothelial cells in atherogenesis and cyclic amp phospho di esterase inhibitor in the prevention and treatment of athero sclerotic disorders. Russek, Henry I (Ed ) New Horizons in Cardiovascular Practice Proceedings Of The Sixth Annual Symposium Of The American College Of Cardiology, New York, N Y , U S A Dec 14-16, 1973 Xviii+521p Illus University Park Press: Baltimore, Md , U S A ; London, England Isbn 0-8301-0763-3 449-469, 1975

Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical. American Journal of Pathology 136(2): 451-459, 1990

In vitro and in vivo prevention of human CD8+ CTL-mediated xenocytotoxicity by pig c-FLIP expression in porcine endothelial cells. American Journal of Transplantation 8(2): 288-297, 2008

Bradykinin-mediated prevention of angiotensin II-induced hypertrophy in vitro is critically dependent on endothelial cells. Circulation 94(8 SUPPL ): I230, 1996

Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria. Official Gazette of the United States Patent & Trademark Office Patents 1205(5): 3811, Dec 30, 1997

Potentiation of C1 inhibitor plus heparin in prevention of complement-mediated activation of endothelial cells in a model of xenograft hyperacute rejection. Transplantation Proceedings 26(3): 1246-1247, 1994

Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 56(5): 1171-1176, 1993

Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. European Journal of Cell Biology 78(1): 44-55, 1999

Prevention of gastric damage by NO-releasing aspirin is mediated by inhibition of ICE/-like proteases in gastric mucosa and endothelial cells. Gastroenterology 114(4 PART 2): A122, April 15, 1998

Prevention of Osmotic Injury to Human Umbilical Vein Endothelial Cells for Biopreservation: A First Step Toward Biobanking of Endothelial Cells for Vascular Tissue Engineering. Tissue Engineering. Part C, Methods 22(3): 270-279, 2015

Adenoviral-mediated overexpression of I(kappa)B(alpha) in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 62(7): 967-972, 1996

Endothelial progenitor cells induce a phenotype shift in differentiated endothelial cells towards PDGF/PDGFRβ axis-mediated angiogenesis. Plos One 5(11): E14107-E14107, 2011

Multiple pathways in prevention of immune-mediated brain disorders: Implications for the prevention of autism. Journal of Neuroimmunology 217(1-2): 8-9, 2009

Endothelial HLA class II induction mediated by allogeneic T cells activated by cytomegalovirus-infected cultured endothelial cells. Transplantation Proceedings 25(1 Pt 2): 1439-1440, 1993